TY - JOUR
T1 - Evidence for pentagalloyl glucose binding to human salivary α-amylase through aromatic amino acid residues
AU - Gyémánt, Gyöngyi
AU - Zajácz, Ágnes
AU - Bécsi, Bálint
AU - Ragunath, Chandran
AU - Ramasubbu, Narayanan
AU - Erdodi, Ferenc
AU - Batta, Gyula
AU - Kandra, Lili
N1 - Funding Information:
This work was supported by the Hungarian Research Funds (OTKA T047075, K68416, and NK68578), National Office for Research and Technology of Hungary (BIOINKUB-DEBIOINK) and USPHS grant DE1285 (N.R.).
PY - 2009/2
Y1 - 2009/2
N2 - We demonstrate here that pentagalloyl glucose (PGG), a main component of gallotannins, was an effective inhibitor of HSA and it exerted similar inhibitory potency to Aleppo tannin used in this study. The inhibition of HSA by PGG was found to be non-competitive and inhibitory constants of KEI = 2.6 μM and KESI = 3.9 μM were determined from Lineweaver-Burk secondary plots. PGG as a model compound for gallotannins was selected to study the inhibitory mechanism and to characterize the interaction of HSA with this type of molecules. Surface plasmon resonance (SPR) binding experiments confirmed the direct interaction of HSA and PGG, and it also established similar binding of Aleppo tannin to HSA. Saturation transfer difference (STD) experiment by NMR clearly demonstrated the aromatic rings of PGG may be involved in the interaction suggesting a possible stacking with the aromatic side chains of HSA. The role of aromatic amino acids of HSA in PGG binding was reinforced by kinetic studies with the W58L and Y151M mutants of HSA: the replacement of the active site aromatic amino acids with aliphatic ones decreased the PGG inhibition dramatically, which justified the importance of these residues in the interaction.
AB - We demonstrate here that pentagalloyl glucose (PGG), a main component of gallotannins, was an effective inhibitor of HSA and it exerted similar inhibitory potency to Aleppo tannin used in this study. The inhibition of HSA by PGG was found to be non-competitive and inhibitory constants of KEI = 2.6 μM and KESI = 3.9 μM were determined from Lineweaver-Burk secondary plots. PGG as a model compound for gallotannins was selected to study the inhibitory mechanism and to characterize the interaction of HSA with this type of molecules. Surface plasmon resonance (SPR) binding experiments confirmed the direct interaction of HSA and PGG, and it also established similar binding of Aleppo tannin to HSA. Saturation transfer difference (STD) experiment by NMR clearly demonstrated the aromatic rings of PGG may be involved in the interaction suggesting a possible stacking with the aromatic side chains of HSA. The role of aromatic amino acids of HSA in PGG binding was reinforced by kinetic studies with the W58L and Y151M mutants of HSA: the replacement of the active site aromatic amino acids with aliphatic ones decreased the PGG inhibition dramatically, which justified the importance of these residues in the interaction.
KW - Human salivary α-amylase inhibition
KW - NMR
KW - Pentagalloyl glucose
KW - Saturation transfer difference
KW - Surface plasmon resonance
UR - http://www.scopus.com/inward/record.url?scp=58149191215&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=58149191215&partnerID=8YFLogxK
U2 - 10.1016/j.bbapap.2008.10.012
DO - 10.1016/j.bbapap.2008.10.012
M3 - Article
C2 - 19038368
AN - SCOPUS:58149191215
SN - 1570-9639
VL - 1794
SP - 291
EP - 296
JO - Biochimica et Biophysica Acta - Proteins and Proteomics
JF - Biochimica et Biophysica Acta - Proteins and Proteomics
IS - 2
ER -